Podcast Episodes

Back to Search
Yong'an Futures' net profit in the third quarter of two thousand twenty-five reached its peak
Yong'an Futures' net profit in the third quarter of two thousand twenty-five reached its peak

Smf5Yv7iSAZW7lGwgunC

10 months, 1 week ago

Short Long
View Episode
Joining Hands to Create the Future | Caesar Travel and HNA Aviation Group
Joining Hands to Create the Future | Caesar Travel and HNA Aviation Group

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Two thousand twenty-five SIOP | InnoCare Pharma Zoledronic Acid Research Selected
Two thousand twenty-five SIOP | InnoCare Pharma Zoledronic Acid Research Selected

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Zhiyuan Internet: Leading the way with double crown, creating a new benchmark for AI
Zhiyuan Internet: Leading the way with double crown, creating a new benchmark for AI

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Helenze service team gallops across the snow covered plateau, and guards the power lifeline
Helenze service team gallops across the snow covered plateau, and guards the power lifeline

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Hai Lu Beverage made its debut at the threerd CATA Aviation Conference
Hai Lu Beverage made its debut at the threerd CATA Aviation Conference

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Xu Jiangtao from Swan Group Xinjiang Company was awarded the title of "Craftsman of the Year"
Xu Jiangtao from Swan Group Xinjiang Company was awarded the title of "Craftsman of the Year"

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Ningxia's richest man struggles to suppress investment impulse, high growth Baofeng Energy's
Ningxia's richest man struggles to suppress investment impulse, high growth Baofeng Energy's

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Heavy weight! The Phase III clinical trial of the innovative Chinese medicine "Wendan Tablet"
Heavy weight! The Phase III clinical trial of the innovative Chinese medicine "Wendan Tablet"

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode
Pien Tze Huang: Third quarter performance increased by fifty-five% compared to
Pien Tze Huang: Third quarter performance increased by fifty-five% compared to

Smf5Yv7iSAZW7lGwgunC

10 months, 2 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us